TromboCare
Evaluate your genetic predisposition to thromboembolic risk
TromboCare is a genetic tool designed to identify a hereditary predisposition to thrombosis—the formation of blood clots in veins or arteries. This condition is directly linked to serious diseases such as acute myocardial infarction, stroke, and venous thromboembolism. Detecting this risk early enables timely, personalised preventive interventions that can make a significant difference in long-term health
The TromboCare test analyses 15 genetic variants in 11 key genes of the coagulation system. These variants are associated with deficiencies in natural coagulation inhibitors and alterations in coagulation factor synthesis. Thanks to this high-precision technology (99%), patients can accurately uncover their genetic profile and make informed decisions about their cardiovascular health.
Who is it aimed at?
Women with a history of recurrent miscarriage, pre-eclampsia, placental abruption, or fetal loss.
Women planning to start hormone replacement therapy (HRT) or contraceptive treatments.
Individuals without a history of VTE but exposed to risk factors such as surgery or obesity.
Individuals with a personal or family history of thromboembolic events.
Clinical application and preventive treatment
TromboCare is a scientifically validated genetic study with proven clinical relevance. Its results enable healthcare professionals to design personalised prevention and treatment strategies. In cases of confirmed risk, management typically involves oral anticoagulant therapy, helping prevent new clot formation and manage existing ones. This therapy must always be prescribed and monitored by a specialist.
Test procedure
Sample collection
Blood sample collected via venipuncture into an EDTA tube by a healthcare professional.
Analysis
Genetic processing conducted at our specialized laboratory.
Results
A detailed report is delivered within 10 days of sample arrival at the laboratory.
Recommendations
Following risk confirmation, preventive oral anticoagulant therapy may be initiated to prevent new thrombi formation and manage existing ones. Management must always be prescribed and monitored by a haematologist.
Key benefits
It facilitates preventive measures, such as lifestyle adjustments and anticoagulant therapy, reducing the risk of complications.
In the event of a positive result, the test enables safer and more informed decisions, especially when planning a pregnancy.
The test helps assess the risk of developing thrombophilia, both individually and within the family.